Chiauranib
Chiauranib Uses, Dosage, Side Effects, Food Interaction and all others data.
Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).
| Trade Name | Chiauranib |
| Generic | Chiauranib |
| Type | |
| Formula | C27H21N3O3 |
| Weight | Average: 435.483 Monoisotopic: 435.158291548 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Chiauranib
